Please use this identifier to cite or link to this item:
|Title:||Fractal correlation property of heart rate variability in chronic obstructive pulmonary disease|
|Authors:||Carvalho, Tatiana Dias de [UNIFESP]|
Pastre, Carlos Marcelo
Godoy, Moacir Fernandes de
Fereira, Celso [UNIFESP]
Pitta, Fabio O.
Abreu, Luiz Carlos de
Ramos, Ercy Mara Cipulo [UNIFESP]
Valenti, Vitor Engrácia [UNIFESP]
Vanderlei, Luiz Carlos Marques
Univ Estadual Paulista
Universidade Federal de São Paulo (UNIFESP)
Fac Med Sao Jose do Rio Preto
Universidade Estadual de Londrina (UEL)
Fac Med ABC
|Publisher:||Dove Medical Press Ltd|
|Citation:||International Journal of Chronic Obstructive Pulmonary Disease. Albany: Dove Medical Press Ltd, v. 6, p. 23-28, 2011.|
|Abstract:||Background: It was reported that autonomic nervous system function is altered in subjects with chronic obstructive pulmonary disease (COPD). We evaluated short-and long-term fractal exponents of heart rate variability (HRV) in COPD subjects.Patients and methods: We analyzed data from 30 volunteers, who were divided into two groups according to spirometric values: COPD (n = 15) and control (n = 15). for analysis of HRV indices, HRV was recorded beat by beat with the volunteers in the supine position for 30 minutes. We analyzed the linear indices in the time (SDNN [standard deviation of normal to normal] and RMSSD [root-mean square of differences]) and frequency domains (low frequency [LF], high frequency [HF], and LF/HF), and the short-and long-term fractal exponents were obtained by detrended fluctuation analysis. We considered P < 0.05 to be a significant difference.Results: COPD patients presented reduced levels of all linear exponents and decreased short-term fractal exponent (alpha-1: 0.899 +/- 0.18 versus 1.025 +/- 0.09, P = 0.026). There was no significant difference between COPD and control groups in alpha-2 and alpha-1/alpha-2 ratio.Conclusion: COPD subjects present reduced short-term fractal correlation properties of HRV, which indicates that this index can be used for risk stratification, assessment of systemic disease manifestations, and therapeutic procedures to monitor those patients.|
|Appears in Collections:||Em verificação - Geral|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.